Sarepta Therapeutics, Inc. (SRPT)
18.13
-0.66
(-3.51%)
USD |
NASDAQ |
Aug 24, 16:00
18.13
0.00 (0.00%)
After-Hours: 20:00
Sarepta Therapeutics Shareholders Equity (Quarterly) : 1.528B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.528B |
| March 31, 2026 | 1.505B |
| December 31, 2025 | 1.141B |
| September 30, 2025 | 1.320B |
| June 30, 2025 | 1.357B |
| March 31, 2025 | 1.143B |
| December 31, 2024 | 1.528B |
| September 30, 2024 | 1.221B |
| June 30, 2024 | 1.077B |
| March 31, 2024 | 961.19M |
| December 31, 2023 | 859.34M |
| September 30, 2023 | 764.36M |
| June 30, 2023 | 741.41M |
| March 31, 2023 | 712.75M |
| December 31, 2022 | 384.95M |
| September 30, 2022 | 430.84M |
| June 30, 2022 | 726.46M |
| March 31, 2022 | 856.89M |
| December 31, 2021 | 928.01M |
| September 30, 2021 | 469.53M |
| June 30, 2021 | 485.11M |
| March 31, 2021 | 535.44M |
| December 31, 2020 | 761.76M |
| September 30, 2020 | 892.05M |
| June 30, 2020 | 1.043B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.145B |
| December 31, 2019 | 818.19M |
| September 30, 2019 | 995.20M |
| June 30, 2019 | 1.099B |
| March 31, 2019 | 1.349B |
| December 31, 2018 | 1.032B |
| September 30, 2018 | 639.85M |
| June 30, 2018 | 699.05M |
| March 31, 2018 | 776.76M |
| December 31, 2017 | 789.22M |
| September 30, 2017 | 697.16M |
| June 30, 2017 | 377.77M |
| March 31, 2017 | 429.14M |
| December 31, 2016 | 336.69M |
| September 30, 2016 | 408.62M |
| June 30, 2016 | 121.46M |
| March 31, 2016 | 138.96M |
| December 31, 2015 | 190.35M |
| September 30, 2015 | 123.24M |
| June 30, 2015 | 165.38M |
| March 31, 2015 | 200.76M |
| December 31, 2014 | 247.65M |
| September 30, 2014 | 286.20M |
| June 30, 2014 | 299.92M |
| March 31, 2014 | 228.96M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Moderna, Inc. | 6.761B |
| ImmunityBio, Inc. | -1.047B |
| X4 Pharmaceuticals, Inc. | 155.45M |
| MapLight Therapeutics, Inc. | 348.30M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 3.189B |
| Total Liabilities (Quarterly) | 1.661B |
| Debt to Equity Ratio | 0.6845 |
| Current Ratio | 4.422 |
| Net Debt Paydown Yield | 3.14% |